Alterity Therapeutics-ADRATHE
13F holders, Q4 2024 (December 31)13holders
3new positions
3sold out
1famous investor
$3.35avg. 13F price*
At the end of Q4 2024, 13 institutions reported holding Alterity Therapeutics-ADR (ATHE) in their 13F filings, unchanged from Q3 2024. 3 opened new positions and 3 sold out. The largest holders were Morgan Stanley ($147K), HB Wealth Management, LLC ($110K) and Point72 Asset Management ($108K). One famous investor held it Steve Cohen (0.0% of Point72 Asset Management's portfolio).
- Company
- Alterity Therapeutics-ADR
- CUSIP
- 02155X205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $137K |
| Exits | 3 | $34K |
All 13F filers, Q3 2024 → Q4 2024: 49,633 shares bought and 38,021 shares sold, net +11,612 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Morgan Stanley | 0.00% | Reduce -0.2% | 44,401 | $147K |
| HB Wealth Management, LLC | 0.00% | Add +34.1% | 31,883 | $110K |
| Point72 Asset Management | 0.00% | New | 32,627 | $108K |
| BNP Paribas Financial Markets | 0.00% | New | 8,790 | $29K |
| Twin Lakes Capital Management, LLC | 0.01% | No change | 5,925 | $20K |
| UBS Group AG | 0.00% | Reduce -97.0% | 384 | $1K |
| Osaic Holdings, Inc. | 0.00% | Add +123.5% | 181 | $598 |
| Blue Trust, Inc. | 0.00% | No change | 40 | $132 |
| Sugarloaf Wealth Management, LLC | 0.00% | No change | 33 | $109 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 16 | $53 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 6 | $20 |
| Coppell Advisory Solutions LLC | 0.00% | No change | 5 | $18 |
| Danske Bank A/S | 0.00% | No change | 1 | $3 |
"% of holder's portfolio" is ATHE's weight in each manager's 13F, not the share of Alterity Therapeutics-ADR the manager owns.